Medicare Part D coverage · 0.2 · RxCUI 2634479
0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]
Per the CMS 2026 Part D formulary file, 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] is covered by 127 Medicare Part D plans (2.5% of enrollable products), averaging Tier 4, with prior authorization required on 50% of covering formularies.
- 2.5%
- Plan coverage
- 127
- Plans covering
- T4
- Avg tier
- 50%
- Prior auth required
What the CMS Formulary Data Shows for 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]
Per the CMS 2026 Part D formulary file, 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] (RxNorm concept RXCUI 2634479, generic name 0.2) appears on 4 distinct formulary files spanning 127 Medicare Part D plan offerings - 2.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 5, with a cross-plan average of Tier 4.
Real-world access to 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] depends on utilization management as much as tier placement: 50% of covering formularies require prior authorization. 0% require step therapy. 25% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 127
- Coverage rate
- 2.5%
- Tier range
- Tier 3 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 50% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 25% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] covered by Medicare Part D?
Yes, 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] is covered by 127 Medicare Part D plans (2.5% of all Part D formularies).
What tier is 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] on Medicare Part D plans?
0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] averages Tier 4 across Part D plans, ranging from Tier 3 to Tier 5.
Does 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] require prior authorization?
50% of Part D formularies require prior authorization for 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]. Step therapy: 0%. Quantity limits: 25%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray T4
- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] T4
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia] T4
- timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] T4
- deflazacort 18 MG Oral Tablet [Jaythari] T4
- bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] T4
Similar prior-authorization rate
- memantine hydrochloride 10 MG Oral Tablet 50% PA
- acetaminophen 325 MG / butalbital 50 MG Oral Tablet [Tencon] 50% PA
- methylprednisolone 8 MG Oral Tablet [Medrol] 50% PA
- 72 HR fentanyl 0.025 MG/HR Transdermal System 50% PA
- 72 HR fentanyl 0.075 MG/HR Transdermal System 50% PA
- 168 HR estradiol 0.00104 MG/HR Transdermal System [Climara] 50% PA